Corticosteroid–serotonin interactions in the neurobiological mechanisms of stress-related disorders
The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
Structure and function of the brain serotonin system
Jacobs, B. L., & Azmitia, E. C. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.1.165 · Cited by 2,576
Hippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932 · cited 2×
“Brain imaging studies in humans have evidenced that stress and depression cause reductions of the hippocampal volume (Sheline et al., 1996), probably because of atrophy in dendritic arborizations”
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
JACOBSON, L., & SAPOLSKY, R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-118 · Cited by 1,739
Willner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605 · cited 6×
“In particular, Willner (2005) set up a model adapted from Katz et al. (1981) with slight differences compared to the original chronic variable stress paradigm in the selection of stressors, timing of their presentation, and the behavioral out- comes measured.”
InfluentialPsychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
Cited by
Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects
Mahar, I., Bambico, F. R., Mechawar, N., & Nobrega, J. N. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.009 · Cited by 694
MacQueen, G., & Frodl, T. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.80 · Cited by 665
De Raedt, R., & Koster, E. H. W. (2010) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/cabn.10.1.50 · Cited by 583
5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants
Richardson-Jones, J. W., Craige, C. P., Guiard, B. P., Stephen, A., Metzger, K. L., Kung, H. F., Gardier, A. M., Dranovsky, A., David, D. J., Beck, S. G., et al. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.003 · Cited by 450
Sex Differences in the HPA Axis
Goel, N., Workman, J. L., Lee, T. T., Innala, L., & Viau, V. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130054 · Cited by 378
Stress and the reproductive axis
Toufexis, D., Rivarola, M. A., Lara, H., & Viau, V. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12179 · Cited by 350
Albert, P. R., Vahid-Ansari, F., & Luckhart, C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00199 · Cited by 321
Cortisol and DHEA in development and psychopathology
Kamin, H. S., & Kertes, D. A. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.11.018 · Cited by 311
Impact of early adversity on glucocorticoid regulation and later mental disorders
Strüber, N., Strüber, D., & Roth, G. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.10.015 · Cited by 173
Glucocorticoids Orchestrate Divergent Effects on Mood through Adult Neurogenesis
Lehmann, M. L., Brachman, R. A., Martinowich, K., Schloesser, R. J., & Herkenham, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3878-12.2013 · Cited by 168
“Such behavioral control may be influenced by serotonin activity via 5HT1A receptors and raphe-to-hippocampal serotonergic neurotransmission (Lanfumey et al., 2008).”
BackgroundGoeldner, C., Lutz, P.-E., Darcq, E., Halter, T., Clesse, D., Ouagazzal, A.-M., & Kieffer, B. L. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.021 · Cited by 163
“This transient corticosterone increase could nonetheless contribute to the setting of depressive-like behavior during protracted abstinent, by triggering neuroadaptations in extrahypothalamic neuropeptidic stress circuits (3,24,25,62,63) or by influencing the serotoninergic tone, at pre-synaptic DR level or in forebra…”
BackgroundMcCormack, K., Newman, T. K., Higley, J. D., Maestripieri, D., & Sanchez, M. M. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.01.009 · Cited by 161
“Altogether, these findings are consistent with the important role of serotonin regulating not only HPA stress reactivity, but its negative feedback (Lanfumey et al., 2008; Porter et al., 2004).”
BackgroundAli, S. H., Madhana, R. M., K.V., A., Kasala, E. R., Bodduluru, L. N., Pitta, S., Mahareddy, J. R., & Lahkar, M. (2015) · Steroids · doi:10.1016/j.steroids.2015.05.010 · Cited by 145
“The pro-depressive effect of GC surplus is capable of causing atrophy and decreased neurogenesis in the hippocampus resulting in manifestations of neuroanatomical, molecular as well as behavioral pathology of depression [17,34,35].”
Major depression, cognitive dysfunction and Alzheimer's disease: Is there a link?
Sierksma, A. S. R., van den Hove, D. L. A., Steinbusch, H. W. M., & Prickaerts, J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.021 · Cited by 139
Jazayeri, S., Keshavarz, S. A., Tehrani-Doost, M., Djalali, M., Hosseini, M., Amini, H., Chamari, M., & Djazayery, A. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.04.013 · Cited by 116
“Furthermore, as corticosteroids negatively regulated transcription of serotonin1A (5HT1A) receptor gene, especially in limbic system (Lanfumey et al., 2008), decreasing cortisol can potentially affect serotonin sensitivity and reduce depressive symptoms.”
Martino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111
“So, chronic excess in cortisol levels, index of HPA axis hyperactivity, downregulating 5-HT1A postsynaptic receptors in amygdala and cortex (which play an inhibitory role on glutamatergic tone), could lead to amygdala glutamatergic hyperactivity (and excitotoxicity) due to decrease in 5-HT activity, altering dendrites…”
BackgroundGut-brain axis serotonergic responses to acute stress exposure are microbiome-dependent
Lyte, J. M., Gheorghe, C. E., Goodson, M. S., Kelley‐Loughnane, N., Dinan, T. G., Cryan, J. F., & Clarke, G. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13881 · Cited by 77
Prolonged maternal separation disturbs the serotonergic system during early brain development
Ohta, K., Miki, T., Warita, K., Suzuki, S., Kusaka, T., Yakura, T., Liu, J., Tamai, M., & Takeuchi, Y. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.10.007 · Cited by 68
Fornaro, M., Rocchi, G., Escelsior, A., Contini, P., & Martino, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.007 · Cited by 59
Karabeg, M. M., Grauthoff, S., Kollert, S. Y., Weidner, M., Heiming, R. S., Jansen, F., Popp, S., Kaiser, S., Lesch, K.-P., Sachser, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078238 · Cited by 56
“neuropsychiatric disorders such as major depression and anxiety disorders [1-4].”
BackgroundInfluentialWiebenga, J. X. M., Heering, H. D., Eikelenboom, M., van Hemert, A. M., van Oppen, P., & Penninx, B. W. J. H. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.02.021 · Cited by 53
“These factors are known to be clinically relevant to suicide risk (Forget et al., 2016; Lanfumey et al., 2008; McGirr et al., 2010; Steinberg and Mann, 2020).”
BackgroundSerotonin neuron abnormalities in the BTBR mouse model of autism
Guo, Y., & Commons, K. G. (2017) · Autism Research · doi:10.1002/aur.1665 · Cited by 51
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function
Locatelli, V., Bresciani, E., Tamiazzo, L., & Torsello, A. (2010) · Endocrine development · doi:10.1159/000262533 · Cited by 48
Albert, P., & Fiori, L. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660740 · Cited by 46
Does Maternal Mental Well-Being in Pregnancy Impact The Early Human Epigenome?
Ryan, J., Mansell, T., Fransquet, P., & Saffery, R. (2017) · Epigenomics · doi:10.2217/epi-2016-0118 · Cited by 46
Proulx, É., Young, E. J., Osborne, L. R., & Lambe, E. K. (2010) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-010-9044-5 · Cited by 35
“The hypothalamic-pituitary-adrenal (HPA) axis plays a crucial role in mediating anxiety behaviors and has been shown to interact with the serotonergic neuromodulatory system (Lanfumey et al. 2008).”
BackgroundAbnormal stress responsiveness and suicidal behavior: a risk phenotype
Steinberg, L. J., & Mann, J. J. (2020) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2020.100011 · Cited by 29
Moreno-Ramos, O. A., Lattig, M. C., & González Barrios, A. F. (2013) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-10-59 · Cited by 22
Metadata
- Authors
- Lanfumey, L., Mongeau, R., Cohen-Salmon, C., & Hamon, M.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 32
- Issue
- 6
- Pages
- 1174-1184
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2170165650
- Cited by
- 341
- References
- 147
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.